Carbon Revolution (CREV) late Monday said it reached an agreement with Orion Infrastructure Capital for an extra $25 million in funding that will be distributed in five equal tranches.
Carbon Revolution shares were up 120% in recent trading. Trading volume was sharply higher, with around 24.6 million shares exchanged with about one hour left in the holiday-shortened session compared with a daily average of around 81,100 shares.
NeueHealth (NEUE) late Monday agreed to be acquired and taken private by an affiliate of New Enterprise Associates through a transaction that values the embedded pharmacy, laboratory, radiology services company at around $1.3 billion.
NeueHealth shares recently were gaining over 68%. Trading volume recently had reached nearly 670,000 shares compared with the daily average of around 10,200 shares.
Clearmind Medicine (CMND) has received approval from Yale University to begin a phase 1/2a clinical trial of its CMND-100 drug candidate to treat alcohol-use disorder.
Clearmind Medicine shares were over 37% higher in recent trading. Volume was running significantly higher than usual, with more than 50.1 million shares traded so far on Tuesday compared with a daily average of around 266,000 shares.
Price: 8.56, Change: +4.67, Percent Change: +120.05
